This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Administrators of the Tulane Educational Fund. Active years: 2021-2022.
Company Filing History:
Years Active: 2021-2022
Title: Innovations in HIV Treatment by Stephen E Braun
Introduction
Stephen E Braun is an accomplished inventor based in New Orleans, LA (US). He holds 2 patents that focus on innovative methods for treating HIV using mesenchymal stem cells. His work has the potential to significantly impact the field of virology and regenerative medicine.
Latest Patents
One of his latest patents is titled "Expression of HIV inhibitors by mesenchymal stem cells." This patent discloses a composition of matter and method for treating HIV by transducing mesenchymal stem cells (MSCs) with vectors that incorporate an anti-viral fusion inhibitor. The transduced MSCs can express the inhibitor and prevent HIV virus-cell fusion. Another significant patent is "Small tissue CCR5MSCs for treatment of HIV." This patent outlines a method for obtaining small tissue mesenchymal stem cells from adipose tissue of patients with HIV. These stem cells are gene-edited to create CCR5stMSCs, which can repopulate the patient with stem cells that are resistant to HIV.
Career Highlights
Stephen E Braun has worked with notable institutions such as the Administrators of the Tulane Educational Fund and Tulane University. His contributions to the field of HIV research have been recognized for their innovative approach to treatment.
Collaborations
Throughout his career, Braun has collaborated with esteemed colleagues, including Debasis Mondal and Bruce Alan Bunnell. These partnerships have furthered his research and development efforts in the field of stem cell therapy.
Conclusion
Stephen E Braun's innovative patents and research in HIV treatment highlight his significant contributions to medical science. His work with mesenchymal stem cells offers promising avenues for future therapies against HIV.